May 2017

Taithera is a revolutionary nanomedicine bone targeted drug delivery and controlled release platform technology for the treatment of musculoskeletal conditions focused initially on fracture healing & bone cancer metastases.

Gero uses proprietary biological data analysis tools to identify potential human anti-aging targets and develop therapeutic interventions that will prolong human lifespan and healthspan.

TargaGenix is developing novel cancer therapeutics to address un-met medical needs.

Ionica Sciences is developing a platform diagnostic for infectious diseases using a novel spectroscopic detection mechanism, and our first target is Lyme disease.

SCIPHER (DZZOM) has developed a blood test that predicts if a patient will respond to Humira before the drug is actually prescribed that potentially will save the health insurance industry billions.


Leave a comment